Literature DB >> 11790214

Characteristics and outcomes in adult patients receiving mechanical ventilation: a 28-day international study.

Andrés Esteban1, Antonio Anzueto, Fernando Frutos, Inmaculada Alía, Laurent Brochard, Thomas E Stewart, Salvador Benito, Scott K Epstein, Carlos Apezteguía, Peter Nightingale, Alejandro C Arroliga, Martin J Tobin.   

Abstract

CONTEXT: The outcome of patients receiving mechanical ventilation for particular indications has been studied, but the outcome in a large number of unselected, heterogeneous patients has not been reported.
OBJECTIVE: To determine the survival of patients receiving mechanical ventilation and the relative importance of factors influencing survival. DESIGN, SETTING, AND
SUBJECTS: Prospective cohort of consecutive adult patients admitted to 361 intensive care units who received mechanical ventilation for more than 12 hours between March 1, 1998, and March 31, 1998. Data were collected on each patient at initiation of mechanical ventilation and daily throughout the course of mechanical ventilation for up to 28 days. MAIN OUTCOME MEASURE: All-cause mortality during intensive care unit stay.
RESULTS: Of the 15 757 patients admitted, a total of 5183 (33%) received mechanical ventilation for a mean (SD) duration of 5.9 (7.2) days. The mean (SD) length of stay in the intensive care unit was 11.2 (13.7) days. Overall mortality rate in the intensive care unit was 30.7% (1590 patients) for the entire population, 52% (120) in patients who received ventilation because of acute respiratory distress syndrome, and 22% (115) in patients who received ventilation for an exacerbation of chronic obstructive pulmonary disease. Survival of unselected patients receiving mechanical ventilation for more than 12 hours was 69%. The main conditions independently associated with increased mortality were (1) factors present at the start of mechanical ventilation (odds ratio [OR], 2.98; 95% confidence interval [CI], 2.44-3.63; P<.001 for coma), (2) factors related to patient management (OR, 3.67; 95% CI, 2.02-6.66; P<.001 for plateau airway pressure >35 cm H(2)O), and (3) developments occurring over the course of mechanical ventilation (OR, 8.71; 95% CI, 5.44-13.94; P<.001 for ratio of PaO(2) to fraction of inspired oxygen <100).
CONCLUSION: Survival among mechanically ventilated patients depends not only on the factors present at the start of mechanical ventilation, but also on the development of complications and patient management in the intensive care unit.

Entities:  

Mesh:

Year:  2002        PMID: 11790214     DOI: 10.1001/jama.287.3.345

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  399 in total

1.  Central venous access in intensive care unit patients: is the subclavian vein the royal route?

Authors:  Jean-François Timsit
Journal:  Intensive Care Med       Date:  2002-08       Impact factor: 17.440

2.  Ventilator-induced lung injury, cytokines, PEEP, and mortality: implications for practice and for clinical trials.

Authors:  Arthur S Slutsky; Yumiko Imai
Journal:  Intensive Care Med       Date:  2003-08       Impact factor: 17.440

3.  Barotrauma during mechanical ventilation: why aren't we seeing any more?

Authors:  Jean-Damien Ricard
Journal:  Intensive Care Med       Date:  2004-02-24       Impact factor: 17.440

4.  Prospectively defined indicators to improve the safety and quality of care for critically ill patients: a report from the Task Force on Safety and Quality of the European Society of Intensive Care Medicine (ESICM).

Authors:  A Rhodes; R P Moreno; E Azoulay; M Capuzzo; J D Chiche; J Eddleston; R Endacott; P Ferdinande; H Flaatten; B Guidet; R Kuhlen; C León-Gil; M C Martin Delgado; P G Metnitz; M Soares; C L Sprung; J F Timsit; A Valentin
Journal:  Intensive Care Med       Date:  2012-01-26       Impact factor: 17.440

5.  Severity of acute illness is associated with baseline readiness to change in medical intensive care unit patients with unhealthy alcohol use.

Authors:  Brendan J Clark; Alexandra Smart; Robert House; Ivor Douglas; Ellen L Burnham; Marc Moss
Journal:  Alcohol Clin Exp Res       Date:  2011-09-26       Impact factor: 3.455

6.  A prospective international observational prevalence study on prone positioning of ARDS patients: the APRONET (ARDS Prone Position Network) study.

Authors:  C Guérin; P Beuret; J M Constantin; G Bellani; P Garcia-Olivares; O Roca; J H Meertens; P Azevedo Maia; T Becher; J Peterson; A Larsson; M Gurjar; Z Hajjej; F Kovari; A H Assiri; E Mainas; M S Hasan; D R Morocho-Tutillo; L Baboi; J M Chrétien; G François; L Ayzac; L Chen; L Brochard; A Mercat
Journal:  Intensive Care Med       Date:  2017-12-07       Impact factor: 17.440

7.  Diaphragm muscle fiber weakness and ubiquitin-proteasome activation in critically ill patients.

Authors:  Pleuni E Hooijman; Albertus Beishuizen; Christian C Witt; Monique C de Waard; Armand R J Girbes; Angelique M E Spoelstra-de Man; Hans W M Niessen; Emmy Manders; Hieronymus W H van Hees; Charissa E van den Brom; Vera Silderhuis; Michael W Lawlor; Siegfried Labeit; Ger J M Stienen; Koen J Hartemink; Marinus A Paul; Leo M A Heunks; Coen A C Ottenheijm
Journal:  Am J Respir Crit Care Med       Date:  2015-05-15       Impact factor: 21.405

8.  Guidelines for diagnosis and management of chronic obstructive pulmonary disease: Joint ICS/NCCP (I) recommendations.

Authors:  Dheeraj Gupta; Ritesh Agarwal; Ashutosh Nath Aggarwal; V N Maturu; Sahajal Dhooria; K T Prasad; Inderpaul S Sehgal; Lakshmikant B Yenge; Aditya Jindal; Navneet Singh; A G Ghoshal; G C Khilnani; J K Samaria; S N Gaur; D Behera
Journal:  Lung India       Date:  2013-07

Review 9.  Noninvasive positive-pressure ventilation in acute respiratory failure.

Authors:  Oscar Peñuelas; Fernando Frutos-Vivar; Andrés Esteban
Journal:  CMAJ       Date:  2007-11-06       Impact factor: 8.262

10.  Pulse pressure variations to predict fluid responsiveness: influence of tidal volume.

Authors:  Daniel De Backer; Sarah Heenen; Michael Piagnerelli; Marc Koch; Jean-Louis Vincent
Journal:  Intensive Care Med       Date:  2005-03-08       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.